Our Team
Kari McWhorter, LVA, BS, Graduate MLS -  Interdisciplinary Principal Investigator, Research and Development Innovations
Laci Altman, BS -  Biospecimen and Protocol Operations Lead
Bree Poz, Business Management & Functional Medicine - Wellness Program Lead
Peter Shafer, CRS & CRFS - Strategic Advisor for Behavioral Health Prevention & Clinical  Integration
Kelly Rhodes, CRSS, CRS, FPS - Strategic Advisor for Recovery Community Engagement
With Professional Collaborators
Raj Manjeesh, IT- Business 
Dr. Rohini Ganjoo, Advanced Scientific Expertise- Molecular Pathology

 

Founded to address unmet needs of the conventional system lacking the capacity to be proactive during neurodevelopment stages- stage of priming for biological cascades towards manifesting alcohol and substance use disorders- BioSynBoros combines cutting-edge biotechnology with ethical machine learning to provide diagnostic clarity and personalized intervention strategies. 

Along the line, we have developed interventions and systems where devices and pharmacological formulations will intervene in poly-drug Overdoses where the current systems lack the capacity to do so.

We value transparency, patient empowerment, and scientific rigor to improve health outcomes globally.  First, we do no harm and that includes harm by negligence.

Disclaimer: Biosynboros, Inc. does not maintain or desire to obtain status as a clinical medicine practice.  Nor does Biosynboros, Inc. claim to prevent or cure any medical disease or condition.